Type 1 diabetes

Clinical phenotyping of people living with type 1 diabetes according to their levels of diabetes-related distress: results from the SFDT1 cohort

BMJ Open Diabetes Res CarePublished Cross-sectional study

Authors' conclusion

We provide a holistic clinical phenotyping approach that enables the identification of determinants and prevalence of DD, overall and according to key DD subdimensions, in a large and diverse population. Our results underscore the importance of developing DD-targeted prevention and intervention strategies focused specifically on high-risk groups and the most impactful distress subdimensions to reduce the impact of type 1 diabetes burden.

Study context

Population
Adults with T1D from the SFDT1 cohort who completed the Problem Areas in Diabetes questionnaire (PAID ≥40 = high DD); 50.6% female, age 42 years (SD 13.9), diabetes duration 24.7 years (13.6)
Participants
1,220 adults
Outcome
Diabetes-related distress (PAID ≥40 indicates high DD)
Methodological detailscohort-based (SFDT1), age and sex-adjusted multivariable logistic regression
  • Cohort-based (SFDT1)
  • Age and sex-adjusted multivariable logistic regression

Main finding

As reported in the abstract

Diabetes-related distress (PAID)
Total PAID score, mean (SD)
39.6 (21.7)
High DD (PAID ≥40)
592 (48.5%)
Females, younger age, social vulnerability, smoking and retinopathy positively associated with high DD
p<0.05
Anxiety/depression, poor sleep quality and treatment burden strongly associated with DD
p<0.001

Observational data: associations, not effects.

Further findings

Leading DD subdimensions, mean (SD)

Fear of complications
50.1 (24.4)
Diabetes burnout
45.9 (24.5)

Original publication

Clinical phenotyping of people living with type 1 diabetes according to their levels of diabetes-related distress: results from the SFDT1 cohort. BMJ Open Diabetes Res Care. Published 24 February 2025. doi:10.1136/bmjdrc-2024-004524

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.